Jeroen van de Pol

104 Chapter 4 References [1] Lunenfeld B, Stratton P. The clinical consequences of an ageing world and preventive strategies. Best Pract Res Clin Obstet Gynaecol 2013;27:643-59. [2] Tommelein E, Mehuys E, Petrovic M et al. Potentially inappropriate prescribing in community- dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol 2015;71:1415-27. [3] Al Hamid A, Ghaleb M, Aljadhey H et al. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol 2014;78:202-17. [4] Warle-van Herwaarden MF, Kramers C, Sturkenboom MC et al. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Saf 2012;35:245-259. [5] Leendertse AJ, Egberts AC, Stoker LJ et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168:1890-96. [6] Sturkenboom M. Eindrapport: Vervolgonderzoek Medicatieveligheid. 2017. URL: https:// www.rijksoverheid.nl/documenten/rapporten/2017/01/31/eindrapport-vervolgonderzoek- medicatieveiligheid [7] McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy 2016;9:143-56. [8] Van Oostrom SH, Picavet HS, de Bruin SR et al. Multimorbidity of chronic diseases and health care utilization in general practice. BMC Fam Pract 2014;15:61-2296-15-61. [9] Nederlands Huisartsen Genootschap (NHG) i.s.m. andere beroepsorganisaties/ instanties/ verenigingen (Dutch College of General Practitioners in collaboration with other professional organisations). Multidisciplinaire Richtlijn Polyfarmacie bij ouderen (Multidisciplinary Guideline Polypharmacy in Elderly). 2012. URL: https://richtlijnen.nhg.org/multidisciplinaire-richtlijnen/ polyfarmacie-bij-ouderen [10] Clyne WB, Blenkinsopp A, Seal R. A Guide to Medication Review. Liverpool, National Prescribing Center NHS 2008. URL: https://www.cff.org.br/userfiles/52%20-%20CLYNE%20W%20A%20 guide%20to%20medication%20review%202008.pdf [11] Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003) 2008;48:23-31. [12] Jokanovic N, Tan EC, van den Bosch D et al. Clinical medication review in Australia: A systematic review. Res Social Adm Pharm 2016;12:384-418. [13] Lenander C, Elfsson B, Danielsson B et al. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial. Scand J Prim Health Care 2014:1-7. [14] Huiskes VJ, Burger DM, van den Ende CH et al. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract 2017;18:5-016-0577-x. [15] Kwint HF, Faber A, Gussekloo J et al. Dissertation: Improving inappropriate medication use for older people in primary care - Home medication review in older patients - a randomised controlled trial in primary care; 2013.